Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgery
- 1 April 1993
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 70 (1) , 67-76
- https://doi.org/10.1016/0049-3848(93)90224-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In Vitro Studies of the Interaction of Heparin, Low Molecular Weight Heparin and Heparinoids with PlateletsAnnals of the New York Academy of Sciences, 1989
- Surgical management of heparin-associated thrombocytopeniaJournal of Vascular Surgery, 1988
- Comparison between a low molecular weight and standard heparin for anticoagulation during extracorporeal CO2 removal in the dogThrombosis Research, 1988
- Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosisBritish Journal of Surgery, 1986
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- Studies on the Antithrombotic Effects and Pharmacokinetics of Heparin Fractions and FragmentsSeminars in Thrombosis and Hemostasis, 1985
- The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparinBlood, 1985
- A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparationThrombosis Research, 1984
- USE OF LOW-MOLECULAR-WEIGHT HEPARIN IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH THROMBOTIC COMPLICATIONSThe Lancet, 1984
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980